Sangamo Biosciences, Inc. (NASDAQ:SGMO)
The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
solanZRaider
(< 20)
Submitted: 1/31/2012 3:54:03 PM :
Start Price:
$3.45
SGMO Score:
+33.03
MylesPatrick & portefeuille
Recs
portefeuille
(99.75)
Submitted: 12/23/2011 5:07:12 AM :
Start Price:
$3.23
SGMO Score:
+38.17
There are currently 7000 SGMO shares in my "fund" with break-even of around 5.04 USD.
http://caps.fool.com/Blogs/fund-trades/678775.
Recs
Turtlebale
(53.90)
Submitted: 10/6/2011 9:25:50 PM :
Start Price:
$3.25
SGMO Score:
+29.10
DN program data out of the way, next news should be better
Recs
siri22
(< 20)
Submitted: 10/3/2011 6:21:54 PM :
Start Price:
$3.00
SGMO Score:
+31.75
Another bio-med with promise
Recs
TMFBiologyFool
(98.28)
Submitted: 9/29/2011 11:59:24 AM :
Start Price:
$4.60
SGMO Score:
-13.30
Good technology, but things need to be worked out. This is more of a buy and forget stock.
Recs
leaderoftheback
(30.01)
Submitted: 9/23/2011 4:33:41 PM :
Start Price:
$5.63
SGMO Score:
-27.45
I'm just rooting for them. I don't know why...just because. Goooooo SGMO!
Recs
elixandre
(< 20)
Submitted: 9/18/2011 2:15:36 PM :
Start Price:
$6.16
SGMO Score:
-35.68
i'm going to buy this immediately. i've been reading about zinc-finger proteins and i'm convinced it's a revolutionary technology to which Sangamo holds almost all the patents.
Recs
edeckerpc
(28.78)
Submitted: 9/13/2011 12:42:36 PM :
Start Price:
$5.88
SGMO Score:
-34.22
ZFN technology is about to pop. It's incredible what they are able to do. This is just the start and SGMO is in a good position for a takeout or major partnership when it hits.
Recs
danyariv314
(< 20)
Submitted: 6/8/2011 5:03:11 AM :
Start Price:
$6.28
SGMO Score:
-29.19
new technnology of zinc finger with great potential in bio-engineering especially conic diseases lie diabetes and not lesser potential for HIV and HIV type. SGMO has manu patents or exclusive licences.
Recs
rofgile
(32.22)
Submitted: 5/30/2011 12:32:45 AM :
Start Price:
$6.72
SGMO Score:
-29.42
Zinc finger binding proteins is good technology (as in, brilliant). They have been working with Sigma-Aldrich (a much larger, and profitable company) to develop this further.
Here's hoping for a little luck and good results.
Recs
mebrownj
(55.65)
Submitted: 3/23/2011 10:23:05 PM :
Start Price:
$7.80
SGMO Score:
-42.20
SGMO has the tools to manipulate genes! Maybe not the definitive ones in the long run, but it will have a nice run until the better tools are developed. If their zinc finger tech can continually improve they will lead the market for the rest of the decade, if not longer.
Recs
Bigdog2020
(76.41)
Submitted: 1/14/2011 5:24:45 PM :
Start Price:
$8.39
SGMO Score:
-47.31
These guys need a hit with their proprietary zinc finger technology... they may get will peripheral neuropathy... a real gamble in a way (not a schrewd, long term investment... perhaps) but the are on to something and sentiment may carry the day.
Recs
kareng13
(< 20)
Submitted: 12/22/2010 1:32:50 PM :
Start Price:
$6.87
SGMO Score:
-38.02
Sangamo BioSciences has a strong therapeutic pipeline with their lead product for Diabetic Neuropathy in Phase II B of development. I would certainly want to be a shareholder once and if the treatment is commercialized. Within the past month and a half, the stock has doubled. I'd get in now.
Recs
pokbluefool
(24.08)
Submitted: 11/4/2010 9:45:41 AM :
Start Price:
$4.09
SGMO Score:
+3.96
SGMO's proprietary Zinc Finger technology is finally gaining traction w/ academia and big pharma. Established relationships with Dow Agro Sciences and Sigma Aldrich starting to drive revenue. Human therapeutics work in HIV and diabetic neuropathy is a potential goldmine. Even at $20 per share, company will ONLY be $1B capitalization. The risk to reward for this stock is OUTRAGEOUS !!!!!!!
Recs
jebiii
(< 20)
Submitted: 4/29/2009 9:09:09 PM :
Start Price:
$4.48
SGMO Score:
-47.78
Genetic engineering technology will dramatically change agriculture and healthcare. HIV treat now in phase I trials.
Recs
pick1998
(90.44)
Submitted: 2/2/2009 4:23:40 PM :
Start Price:
$4.81
SGMO Score:
+65.92
I can name many of reasons to short SGMO (failed neurological pain trial, low cash, basic science of gene therapy...). In one sentence, I think this zinc finger is not yet for human therapy. It may be good for plants, because you can breed a new variety by screening millions of transgenic plants. It is not practical in human being.
Recs
pita99
(< 20)
Submitted: 12/19/2008 9:46:51 PM :
Start Price:
$3.75
SGMO Score:
+28.83
Needs the FDA approval on one of their proposals.
Recs
Windmut
(< 20)
Submitted: 10/14/2008 3:40:30 PM :
Start Price:
$6.98
SGMO Score:
-68.91
Wall street does not understand the business model since it does not match up with any biopharm or pharmaceutical company.
Recs
s03244adir
(30.63)
Submitted: 9/13/2008 4:37:26 PM :
Start Price:
$7.86
SGMO Score:
-53.24
will be bought out
Recs
ltgrowth123
(< 20)
Submitted: 8/20/2008 6:29:13 PM :
Start Price:
$9.86
SGMO Score:
-60.77
Technology of the future
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 55 : 1 2 3 Next »